Ryo Mukai

5.2k total citations
129 papers, 3.3k citations indexed

About

Ryo Mukai is a scholar working on Ophthalmology, Signal Processing and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Ryo Mukai has authored 129 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Ophthalmology, 54 papers in Signal Processing and 34 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Ryo Mukai's work include Speech and Audio Processing (52 papers), Blind Source Separation Techniques (49 papers) and Retinal Diseases and Treatments (44 papers). Ryo Mukai is often cited by papers focused on Speech and Audio Processing (52 papers), Blind Source Separation Techniques (49 papers) and Retinal Diseases and Treatments (44 papers). Ryo Mukai collaborates with scholars based in Japan, United States and South Korea. Ryo Mukai's co-authors include Shoji Makino, Shoko Araki, Hiroshi Sawada, Hidetaka Matsumoto, Shoji Kishi, Hideo Akiyama, Taku Sato, Hiroshi Saruwatari, Junki Hoshino and Kosuke Nakamura and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Ryo Mukai

122 papers receiving 3.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ryo Mukai Japan 29 1.7k 1.3k 1.1k 778 266 129 3.3k
Aaron Carass United States 35 27 0.0× 622 0.5× 85 0.1× 2.3k 2.9× 199 0.7× 184 4.0k
Marinko V. Šarunic Canada 40 14 0.0× 2.6k 2.0× 89 0.1× 2.5k 3.3× 637 2.4× 183 5.3k
Enrico Grisan Italy 24 29 0.0× 976 0.8× 19 0.0× 1.3k 1.6× 166 0.6× 144 2.5k
Qiang Chen China 24 61 0.0× 745 0.6× 6 0.0× 1.1k 1.4× 126 0.5× 110 1.8k
Christian Wachinger Germany 20 29 0.0× 300 0.2× 43 0.0× 1.2k 1.6× 71 0.3× 76 2.6k
Albert C. S. Chung Hong Kong 24 85 0.0× 35 0.0× 66 0.1× 495 0.6× 38 0.1× 113 2.2k
Snehashis Roy United States 20 19 0.0× 194 0.2× 46 0.0× 605 0.8× 119 0.4× 60 1.7k
Emad Fatemizadeh Iran 18 97 0.1× 26 0.0× 68 0.1× 308 0.4× 38 0.1× 120 1.1k
Limin Luo China 17 22 0.0× 54 0.0× 64 0.1× 750 1.0× 214 0.8× 69 1.4k
Kemal Sönmez United States 22 616 0.4× 23 0.0× 40 0.0× 73 0.1× 214 0.8× 61 1.4k

Countries citing papers authored by Ryo Mukai

Since Specialization
Citations

This map shows the geographic impact of Ryo Mukai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryo Mukai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryo Mukai more than expected).

Fields of papers citing papers by Ryo Mukai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryo Mukai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryo Mukai. The network helps show where Ryo Mukai may publish in the future.

Co-authorship network of co-authors of Ryo Mukai

This figure shows the co-authorship network connecting the top 25 collaborators of Ryo Mukai. A scholar is included among the top collaborators of Ryo Mukai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryo Mukai. Ryo Mukai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kataoka, Keiko, Koji Tanaka, Yuto Watanabe, et al.. (2025). Treatment outcomes of switching to aflibercept 8 mg in previously-treated neovascular age-related macular degeneration. Graefe s Archive for Clinical and Experimental Ophthalmology. 264(1). 81–89.
2.
Maehara, Hiroki, Keiichiro Tanaka, Yutaka Kato, et al.. (2024). Complement activation products in tears of dry eye and meibomian gland dysfunction. Scientific Reports. 14(1). 43–43. 4 indexed citations
3.
Mukai, Ryo, et al.. (2024). Exploring the comparative regressive effects of aflibercept and faricimab on pigment epithelial detachment. BMC Ophthalmology. 24(1). 393–393. 6 indexed citations
5.
Mukai, Ryo, et al.. (2023). Micro-abnormalities in the retina and choroid induced by anti-CTLA4 treatment. Scientific Reports. 13(1). 6309–6309. 2 indexed citations
6.
Mukai, Ryo, Hidetaka Matsumoto, Maki Takahashi, et al.. (2023). Comparison of the 2-Year Results of Photodynamic Therapy with Aflibercept and Aflibercept Monotherapy for Polypoidal Choroidal Vasculopathy. Clinical ophthalmology. Volume 17. 571–577. 3 indexed citations
7.
Konno, Ayumu, Nobutake Hosoi, Ryosuke Kaneko, et al.. (2021). GABAergic neuron-specific whole-brain transduction by AAV-PHP.B incorporated with a new GAD65 promoter. Molecular Brain. 14(1). 33–33. 37 indexed citations
8.
Ueno, Shinji, Taro Chaya, Shunsuke Yasuda, et al.. (2021). Broad locations of antigenic regions for anti-TRPM1 autoantibodies in paraneoplastic retinopathy with retinal ON bipolar cell dysfunction. Experimental Eye Research. 212. 108770–108770. 5 indexed citations
9.
Matsumoto, Hidetaka, Junki Hoshino, Ryo Mukai, et al.. (2020). Vortex Vein Anastomosis at the Watershed in Pachychoroid Spectrum Diseases. Ophthalmology Retina. 4(9). 938–945. 97 indexed citations
10.
Akiyama, Hideo, et al.. (2019). ALTERATION OF OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY IN A PATIENT WITH OCULAR ISCHEMIC SYNDROME. Retinal Cases & Brief Reports. 15(5). 588–592. 6 indexed citations
11.
Mukai, Ryo, Dong Ho Park, Yoko Okunuki, et al.. (2019). Mouse model of ocular hypertension with retinal ganglion cell degeneration. PLoS ONE. 14(1). e0208713–e0208713. 24 indexed citations
12.
Mukai, Ryo, et al.. (2018). The Complement System Is Critical in Maintaining Retinal Integrity during Aging. Frontiers in Aging Neuroscience. 10. 15–15. 47 indexed citations
13.
Matsuzaki, Yasunori, Ayumu Konno, Ryo Mukai, et al.. (2016). Transduction Profile of the Marmoset Central Nervous System Using Adeno-Associated Virus Serotype 9 Vectors. Molecular Neurobiology. 54(3). 1745–1758. 18 indexed citations
14.
Mukai, Ryo, et al.. (2014). Instance Search Technology for Finding Specific Objects in Movies. NTT technical review. 12(11). 11–15. 1 indexed citations
15.
Mukai, Ryo, Taku Sato, & Shoji Kishi. (2014). REPAIR MECHANISM OF RETINAL PIGMENT EPITHELIAL TEARS IN AGE-RELATED MACULAR DEGENERATION. Retina. 35(3). 473–480. 26 indexed citations
16.
Akiyama, Hideo, Tomoyuki Kashima, Danjie Li, et al.. (2013). Retinal Ganglion Cell Analysis in Leber's Hereditary Optic Neuropathy. Ophthalmology. 120(9). 1943–1944.e5. 22 indexed citations
17.
Mukai, Ryo, et al.. (2010). NTT Communication Science Laboratories at TRECVID 2010 Content-Based Copy Detection. TRECVID. 9 indexed citations
18.
Mukai, Ryo, Hiroshi Sawada, Shoko Araki, & Shoji Makino. (2004). Blind Source Separation for MOving Speech Signals Using Blockwise ICA and Residual Crosstalk Subtraction. IEICE Transactions on Fundamentals of Electronics Communications and Computer Sciences. 87(8). 1941–1948. 26 indexed citations
19.
Araki, Shoko, et al.. (2003). Blind Separation of More Speech than Sensors with Less Distortion by Combining Sparseness and ICA. 23(3). 341–55. 15 indexed citations
20.
Sawada, Hiroshi, Ryo Mukai, Shoko Araki, & Shoji Makino. (2001). A POLAR-COORDINATE BASED ACTIVATION FUNCTION FOR FREQUENCY DOMAIN BLIND SOURCE SEPARATION. 65(3). 197–203. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026